148 related articles for article (PubMed ID: 10594933)
21. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein synthesis by a toxic lectin from Viscum album L. (mistletoe).
Stirpe F; Legg RF; Onyon LJ; Ziska P; Franz H
Biochem J; 1980 Sep; 190(3):843-5. PubMed ID: 7470084
[TBL] [Abstract][Full Text] [Related]
23. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281
[TBL] [Abstract][Full Text] [Related]
24. Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listeriosis.
Stoffel B; Beuth J; Pulverer G
Zentralbl Bakteriol; 1996 Jul; 284(2-3):439-42. PubMed ID: 8837402
[TBL] [Abstract][Full Text] [Related]
25. [Mistletoe therapy from the pharmacologic perspective].
Hajto T; Hostanska K; Saller R
Forsch Komplementarmed; 1999 Aug; 6(4):186-94. PubMed ID: 10529578
[TBL] [Abstract][Full Text] [Related]
26. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
Jordan E; Wagner H
Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase A or C modulates the apoptosis induced by lectin II isolated from Korean mistletoe, Viscum album var. Coloratum, in the human leukemic HL-60 cells.
Pae HO; Seo WG; Shin M; Lee HS; Lee HS; Kim SB; Chung HT
Immunopharmacol Immunotoxicol; 2000 May; 22(2):279-95. PubMed ID: 10952032
[TBL] [Abstract][Full Text] [Related]
28. Involvement of hydrogen peroxide in mistletoe lectin-II-induced apoptosis of myeloleukemic U937 cells.
Kim MS; Lee J; Lee KM; Yang SH; Choi S; Chung SY; Kim TY; Jeong WH; Park R
Life Sci; 2003 Jul; 73(10):1231-43. PubMed ID: 12850239
[TBL] [Abstract][Full Text] [Related]
29. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
Gabius S; Gabius HJ
Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
[No Abstract] [Full Text] [Related]
30. Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose.
Sweeney EC; Palmer RA; Pfüller U
J Mol Biol; 1993 Dec; 234(4):1279-81. PubMed ID: 8263931
[TBL] [Abstract][Full Text] [Related]
31. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
Büssing A; Schietzel M
Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
[TBL] [Abstract][Full Text] [Related]
34. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.
Stein GM; Edlund U; Pfüller U; Büssing A; Schietzel M
Anticancer Res; 1999; 19(5B):3907-14. PubMed ID: 10628330
[TBL] [Abstract][Full Text] [Related]
35. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts.
Gabius HJ; Darro F; Remmelink M; André S; Kopitz J; Danguy A; Gabius S; Salmon I; Kiss R
Cancer Invest; 2001; 19(2):114-26. PubMed ID: 11296616
[TBL] [Abstract][Full Text] [Related]
36. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I.
Edlund U; Hensel A; Fröse D; Pfüller U; Scheffler A
Arzneimittelforschung; 2000 Jul; 50(7):645-51. PubMed ID: 10965423
[TBL] [Abstract][Full Text] [Related]
37. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
38. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
39. Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum).
Yoon TJ; Yoo YC; Kang TB; Her E; Kim SH; Kim K; Azuma I; Kim JB
Int Immunopharmacol; 2001 May; 1(5):881-9. PubMed ID: 11379043
[TBL] [Abstract][Full Text] [Related]
40. Fine sugar specificity of the mistletoe (Viscum album) lectin I.
Debray H; Montreuil J; Franz H
Glycoconj J; 1994 Dec; 11(6):550-7. PubMed ID: 7696858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
